LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $1.4B | $734M | $256M | $170M | $212M | $341M | $411M | $1.1B | $718M | $202M | $141M | $200M | $167M | $16M | $12M | $17M | $23M | $16M |
| Inventory | $10M | $9.1M | $14M | $24M | $13M | $27M | $26M | $7.3M | $7.1M | $4.4M | $1.9M | $1.6M | $269K | $1.4M | $1.7M | $1.3M | $0 | — |
| Current assets | $1.5B | $832M | $332M | $237M | $264M | $465M | $501M | $1.1B | $871M | $237M | $163M | $215M | $185M | $25M | $24M | $32M | $37M | — |
| Goodwill | $102M | $102M | $105M | $103M | $106M | $106M | $190M | $95M | $87M | $86M | $72M | $12M | $12M | $12M | $12M | $12M | $700K | — |
| Intangible assets | $209M | $225M | $267M | $300M | $342M | $377M | $595M | $210M | $220M | $229M | $205M | $48M | $51M | $53M | $56M | $58M | $12M | — |
| Total assets | $2.2B | $1.6B | $942M | $787M | $763M | $1.3B | $1.4B | $1.5B | $1.3B | $671M | $602M | $503M | $258M | $105M | $104M | $121M | $76M | — |
| Current liabilities | $47M | $37M | $37M | $17M | $99M | $42M | $100M | $17M | $82M | $239M | $227M | $223M | $23M | $29M | $35M | $44M | $33M | — |
| Long-term debt | $1.1B | — | — | — | — | — | — | — | — | — | — | — | — | — | $28M | — | — | — |
| Total liabilities | $1.2B | $543M | $111M | $86M | $165M | $476M | $653M | $728M | $700M | $252M | $231M | $226M | $234M | $55M | $78M | $104M | $72M | — |
| Shareholders' equity | $968M | $1.0B | $830M | $701M | $597M | $821M | $710M | $767M | $561M | $400M | $341M | $237M | $26M | $50M | $26M | $8.2M | −$4.9M | $3.7M |
| Shares outstanding | 19.9M | 19.9M | 19.3M | 17.7M | 17.1M | 16.9M | 16.6M | 16.5M | 20.4M | 21.2M | 20.9M | 20.9M | 19.6M | 19.6M | 20.2M | 19.7M | — | — |
| Current ratio | 31.18 | 22.23 | 8.93 | 14.15 | 2.67 | 11.15 | 5.00 | 66.09 | 10.58 | 0.99 | 0.72 | 0.96 | 8.13 | 0.86 | 0.67 | 0.74 | 1.11 | — |